Hindustan Aeronautics Ltd Q3 Result 2024

Hindustan Aeronautics quarterly result list 2024

Result Snapshot	Q3FY24	Q3FY23	YoY (%)	Q2FY24	QoQ (%)	CEBPL Est.	Dev. (%)
Net Sales (incl 001)	60,613	56,655	7.0	56,357	7.6	73,264	-17.3
Material Exp	28,349	24,897	13.9	23,519	20.5	34,302
Gross Profit	32,264	31,758	1.6	32,838	(1.7)	38,962
Employee Exp	13,005	11,328	14.8	11,959	8.7	12,473
Other Exp	4,906	10,576	(53.6)	5,603	(12.4)	10,914
EBITDA	14,353	9,854	45.7	15,276	(6.0)	15,575	-7.8
Depreciation	2,122	2,689	(21.1)	3,497	(39.3)	3,846
EBIT	12,232	7,166	70.7	11,780	3.8	11,728
Other Income	4,600	4,972	(7.5)	4,694	(2.0)	4,695
Interest Cost	4	21	(82.6)	3.20	12.5	3.00
PBT	16,828	12,117	38.9	16,470	2.2	16,420	2.5
EO Items (Adj For Tax)	67	44
Tax	4,279	578	641.0	4,148	3.2	4,105
RPAT	12,615	11,539	9.3	12,367	2.0	12,315	2.4
APAT	12,565	11,415	10.1	12,334	1.9	12,315	2.0
Adj EPS (Rs)	18.8	17.1	10.1	18.4	1.9	18.4	2.0

Margin Analysis	Q3FY24	Q3FY23	YoY (bps)	Q2FY24	QoQ (bps)	CEBPL Est.	Dev. (bps)
Gross Margin (%)	53.2	56.1	(282.5)	58.3	(503.8)	53.2	4.9
Employee Exp. % of Sales	21.5	20.0	146.1	21.2	23.5	17.0
Other Op. Exp % of Sales	8.1	18.7	(1,057.2)	9.9	(184.7)	14.9
EBITDA Margin (%)	23.68	17.4	628.7	27.1	(342.6)	21.3	242.2
Tax Rate (%)	25%	5%	20.6	25%	0.2	25%
APAT Margin (%)	20.7	20.1	58.3	21.9	(115.5)	16.8

Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.